Pinnacle Wealth Planning Services’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
6,826
+1,735
+34% +$51.3K 0.02% 455
2026
Q1
$141K Buy
5,091
+5,037
+9,328% +$129K 0.01% 621
2025
Q4
$1.17K Buy
+54
New +$1.06K ﹤0.01% 2566

Other funds holding ROIV

Pinnacle Wealth Planning Services's ROIV Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Roivant Sciences (ROIV) stake by 34% in Q2 2026, buying an estimated $51.3K and bringing the position to 6,826 shares worth $242K. The position accounts for 0.02% of the portfolio, ranked #455.

Pinnacle Wealth Planning Services first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Pinnacle Wealth Planning Services held 6,826 shares of Roivant Sciences worth $242K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 1,735 Roivant Sciences shares in Q2 2026, an estimated $51.3K.
  • Roivant Sciences made up 0.02% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #455 holding.
  • Pinnacle Wealth Planning Services first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.